FTC Crackdowns on GLP-1 Scams: Protecting Yourself from Fraud

The GLP-1 medication market's rapid growth has created fertile ground for fraud. From supplements falsely claiming to replicate Ozempic's effects to unlicensed sellers offering prescription medications without proper oversight, the scam landscape is vast. The Federal Trade Commission (FTC) has stepped up enforcement, but consumers remain the first line of defense.

The GLP-1 Scam Landscape

The FTC has identified several categories of GLP-1-related fraud. Fake supplements represent the largest category: products marketed as "natural Ozempic," "herbal GLP-1 activators," or "semaglutide alternatives" that contain no active GLP-1 compounds and have no clinical evidence supporting their claims. These products often use before-and-after photos, fake testimonials, and scientific-sounding language to deceive consumers.

Unlicensed sellers offer what they claim is prescription semaglutide or tirzepatide without proper medical evaluation, often from foreign sources. These products may be counterfeit, contaminated, improperly dosed, or expired. Deceptive pricing schemes advertise low prices but add hidden fees, mandatory subscription minimums, or charge for consultations that were advertised as free.

FTC Enforcement Actions

The FTC has taken multiple enforcement actions in the GLP-1 space. Notable actions include sending cease-and-desist letters to supplement companies making unsupported GLP-1 claims, filing complaints against companies using deceptive advertising for weight loss products, coordinating with the FDA to shut down unlicensed online pharmacies, and issuing consumer alerts about specific scam patterns in the weight loss market.

How to Identify Legitimate Providers

How to Report GLP-1 Fraud

If you encounter a suspected GLP-1 scam, report it to the FTC at ReportFraud.ftc.gov, the FDA's MedWatch program for unsafe medical products, your state attorney general's consumer protection division, and the Better Business Bureau. Your report helps protect other consumers and provides evidence for enforcement actions.

Protecting Yourself

The simplest protection is working with established, transparent providers. Compounded semaglutide and tirzepatide from Trimi are prescribed by licensed providers, dispensed by licensed pharmacies, and priced transparently at $125/mo and $125/mo respectively with no hidden fees. If a deal seems too good to be true, it probably is.

The Bottom Line

As the GLP-1 market grows, so does the scam ecosystem surrounding it. Protect yourself by working with reputable providers, requiring proper medical evaluation, verifying pharmacy licensing, and reporting fraud when you see it. The FTC is actively enforcing, but informed consumers are the best defense against GLP-1 fraud.